| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +7.5K | 0.2% | $7.81 | +$58.6K |
| Sells | 4 | -3.79M | 99.8% | $8.16 | -$30.9M |
| Net | -3 | -3.79M | -99.6% | -$30.9M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 10%+ Owner | $60.5M | Jan 24, 2024 | ||
| James Topper | Director, 10%+ Owner | $53.4M | May 23, 2024 | ||
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $30.4M | -$30M | -49.7% | Jan 24, 2024 |
| Azmi Nabulsi | Chief Operating Officer | $14.8M | -$128K | -0.85% | Jul 15, 2024 |
| David A. Socks | Director | $11.2M | May 23, 2024 | ||
| Terrie Curran | President and Chief Executive, Director | $4.47M | -$550K | -11% | Jul 15, 2024 |
| Molly Henderson | CFO and CBO | $2.33M | -$264K | -10.2% | Jul 15, 2024 |
| Asit Parikh | Director | $597K | +$58.6K | +10.9% | May 23, 2024 |
| Frank Karbe | Director | $452K | May 29, 2024 | ||
| Michael F. Cola | Director | $267K | May 23, 2024 | ||
| Mark Stenhouse | Director | $178K | May 23, 2024 | ||
| Heidi Fields | Director | $178K | May 23, 2024 | ||
| Anthony J. Guzzo | VP, Chief Accounting Officer | $71.8K | Jan 19, 2022 | ||
| Tadataka Yamada | Director | May 21, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|